Search alternatives:
point decrease » point increase (Expand Search)
ns decrease » _ decrease (Expand Search), we decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
point decrease » point increase (Expand Search)
ns decrease » _ decrease (Expand Search), we decrease (Expand Search), use decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
-
421
-
422
-
423
Predicting pattern diversity decreases as a function of and .
Published 2025“…(a) and (b): Average negative predictive value for and , respectively for and . …”
-
424
-
425
-
426
-
427
-
428
-
429
-
430
Systemic metabolic switch and glycogen breakdown are required for effective resistance to <i>Streptococcus pneumoniae</i>.
Published 2018“…Loads, shown in logarithmic scale (values follow lognormal distribution), were compared with unpaired t-tests. (E) and (F) Knocking-down glycogen phosphorylase both specifically in the fat body (<i>ppl>GlyP[RNAi]</i>); purple in panel E) and in the whole flies (<i>Act>GlyP[RNAi]</i>; dark blue in panel F) significantly reduces survival (P<0.0001) when infected with <i>S</i>. …”
-
431
-
432
-
433
-
434
-
435
-
436
PowerPoint Slides for: Urinary Periostin Excretion Predicts Renal Outcome in IgA Nephropathy
Published 2016“…Histologically, group 3 patients were correlated with severe interstitial fibrosis/tubular atrophy (p = 0.004), interstitial inflammation (p = 0.007), hyaline arteriolosclerosis (p = 0.001) and glomerular sclerosis (p < 0.001). A higher initial uPOSTN/Cr level was associated with a greater decline in eGFR during follow-up (p = 0.043 when initial eGFR ≥60; p = 0.025 when eGFR <60 ml/min/1.73 m2), and the renal outcomes with end-stage renal disease (ESRD; p = 0.003), ESRD and/or eGFR decrease of >30% (p = 0.033) and ESRD and/or eGFR decrease of >50% (p = 0.046) occurred significantly more in group 3. …”
-
437
-
438
-
439
-
440